Skip to main content
Erschienen in: Wiener klinische Wochenschrift 21-22/2012

01.11.2012 | original article

Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society

verfasst von: Hakan Cetin, MD, Dr. Gerhard Fülöp, Heidemarie Zach, MD, Prof. Eduard Auff, MD, Fritz Zimprich, MD, PhD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2012

Einloggen, um Zugang zu erhalten

Summary

Objective

The purpose of this study was to investigate recent epidemiological trends of myasthenia gravis (MG) in Austria.

Methods

We used the national hospital discharge register, which records the discharge diagnoses of all inpatient stays in Austria to calculate the yearly inpatient prevalence of MG from 1992 to 2009 (main or secondary diagnosis of MG). The population prevalence was indirectly estimated. The temporal and geographical variability of the inpatient prevalence was correlated with the number of practicing neurologists.

Results

The inpatient prevalence of 2009 was calculated as 8.0 and the population prevalence as 15.69 (95 % CI 13.16–19.42) per 100,000. We observed a 2.2 fold increase in the inpatient prevalence between 1992 and 2009, which was mainly due to a rise in the number of older patients (³ 50 years). Partly this could be accounted for by an ageing of the population as a whole and a rise in the age of hospitalised patients. However, after adjusting for demographic factors an unexplained average yearly rise of 3.7–3.9 % remained. We found a significant spatial and temporal correlation of MG inpatient prevalence rates with the number of practicing neurologists, which increased over the same period.

Conclusions

The results from this study support the notion that the prevalence rate of MG in Austria is rising and near the higher end of the wide range discussed in the literature. Our data argue for the importance of specialist neurological care for the diagnosis of this disease.
Literatur
1.
Zurück zum Zitat Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8:475–90.PubMedCrossRef Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8:475–90.PubMedCrossRef
2.
Zurück zum Zitat Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest. 2006;116:2843–54.PubMedCrossRef Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest. 2006;116:2843–54.PubMedCrossRef
3.
Zurück zum Zitat Zimprich F, Assem-Hilger E. Myasthenia gravis. J Neurol Neurochir Psychiatr. 2010;11(2):52–63. Zimprich F, Assem-Hilger E. Myasthenia gravis. J Neurol Neurochir Psychiatr. 2010;11(2):52–63.
4.
Zurück zum Zitat McGrogan A, Sneddon S, de Vries CS. The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology. 2010;34:171–83.PubMedCrossRef McGrogan A, Sneddon S, de Vries CS. The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology. 2010;34:171–83.PubMedCrossRef
5.
Zurück zum Zitat Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010;10:46.PubMedCrossRef Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010;10:46.PubMedCrossRef
6.
Zurück zum Zitat Phillips LH, 2nd. The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 2003;998:407–12.PubMedCrossRef Phillips LH, 2nd. The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 2003;998:407–12.PubMedCrossRef
8.
Zurück zum Zitat Casetta I, Groppo E, De Gennaro R, Cesnik E, Piccolo L, Volpato S, et al. Myasthenia gravis: a changing pattern of incidence. J Neurol. 2010;257:2015–19.PubMedCrossRef Casetta I, Groppo E, De Gennaro R, Cesnik E, Piccolo L, Volpato S, et al. Myasthenia gravis: a changing pattern of incidence. J Neurol. 2010;257:2015–19.PubMedCrossRef
9.
Zurück zum Zitat Phillips LH, 2nd, Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology. 1996;47(5):1233–8.PubMedCrossRef Phillips LH, 2nd, Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology. 1996;47(5):1233–8.PubMedCrossRef
10.
Zurück zum Zitat Weichbold V, Bertel A, Pelzer A, Pfeiffer KP, Ferenci P. Hepatitis B and C: incidence and regional distribution of hospitalizations in Austria. Wien Klin Wochenschr. 2000;112:995–1001.PubMed Weichbold V, Bertel A, Pelzer A, Pfeiffer KP, Ferenci P. Hepatitis B and C: incidence and regional distribution of hospitalizations in Austria. Wien Klin Wochenschr. 2000;112:995–1001.PubMed
11.
Zurück zum Zitat Strauss R, Fulop G, Pfeifer C. Hepatitis C in Austria 1993–2000: reporting bias distort HCV epidemiology in Austria. Euro Surveill. 2003;8:113–8.PubMed Strauss R, Fulop G, Pfeifer C. Hepatitis C in Austria 1993–2000: reporting bias distort HCV epidemiology in Austria. Euro Surveill. 2003;8:113–8.PubMed
12.
Zurück zum Zitat Wirtz PW, van Dijk JG, van Doorn PA, et al. The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands. Neurology. 2004;63(2):397–8.PubMedCrossRef Wirtz PW, van Dijk JG, van Doorn PA, et al. The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands. Neurology. 2004;63(2):397–8.PubMedCrossRef
13.
Zurück zum Zitat Oh SJ, Morgan MB, Lu L, Hatanaka Y, Hemmi S, Young A, et al. Racial differences in myasthenia gravis in Alabama. Muscle Nerve. 2009;39:328–32.PubMedCrossRef Oh SJ, Morgan MB, Lu L, Hatanaka Y, Hemmi S, Young A, et al. Racial differences in myasthenia gravis in Alabama. Muscle Nerve. 2009;39:328–32.PubMedCrossRef
14.
Zurück zum Zitat Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009;72:1548–54.PubMedCrossRef Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009;72:1548–54.PubMedCrossRef
15.
Zurück zum Zitat Bateman KJ, Schinkel M, Little F, Liebenberg L, Vincent A, Heckmann JM. Incidence of seropositive myasthenia gravis in Cape Town and South Africa. S Afr Med J. 2007;97:959–62.PubMed Bateman KJ, Schinkel M, Little F, Liebenberg L, Vincent A, Heckmann JM. Incidence of seropositive myasthenia gravis in Cape Town and South Africa. S Afr Med J. 2007;97:959–62.PubMed
16.
Zurück zum Zitat Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol. 1991;48:733–9.PubMedCrossRef Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol. 1991;48:733–9.PubMedCrossRef
17.
Zurück zum Zitat Ferrari G, Lovaste MG. Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology. 1992;11:135–42.PubMedCrossRef Ferrari G, Lovaste MG. Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology. 1992;11:135–42.PubMedCrossRef
18.
Zurück zum Zitat Mantegazza R, Baggi F, Antozzi C, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci. 2003;998:413–23.PubMedCrossRef Mantegazza R, Baggi F, Antozzi C, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci. 2003;998:413–23.PubMedCrossRef
19.
Zurück zum Zitat Somnier FE. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology. 2005;65:928–30.PubMedCrossRef Somnier FE. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology. 2005;65:928–30.PubMedCrossRef
20.
Zurück zum Zitat Aarli JA. Myasthenia gravis in the elderly: Is it different? Ann N Y Acad Sci. 2008;1132:238–43.PubMedCrossRef Aarli JA. Myasthenia gravis in the elderly: Is it different? Ann N Y Acad Sci. 2008;1132:238–43.PubMedCrossRef
Metadaten
Titel
Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society
verfasst von
Hakan Cetin, MD
Dr. Gerhard Fülöp
Heidemarie Zach, MD
Prof. Eduard Auff, MD
Fritz Zimprich, MD, PhD
Publikationsdatum
01.11.2012
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 21-22/2012
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-012-0258-2

Weitere Artikel der Ausgabe 21-22/2012

Wiener klinische Wochenschrift 21-22/2012 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in Wien

Mitteilungen November 2012